UniProt ID | HNRDL_HUMAN | |
---|---|---|
UniProt AC | O14979 | |
Protein Name | Heterogeneous nuclear ribonucleoprotein D-like | |
Gene Name | HNRNPDL | |
Organism | Homo sapiens (Human). | |
Sequence Length | 420 | |
Subcellular Localization | Nucleus . Cytoplasm . Shuttles between the nucleus and the cytoplasm in a TNPO1-dependent manner. | |
Protein Description | Acts as a transcriptional regulator. Promotes transcription repression. Promotes transcription activation in differentiated myotubes (By similarity). Binds to double- and single-stranded DNA sequences. Binds to the transcription suppressor CATR sequence of the COX5B promoter (By similarity). Binds with high affinity to RNA molecules that contain AU-rich elements (AREs) found within the 3'-UTR of many proto-oncogenes and cytokine mRNAs. Binds both to nuclear and cytoplasmic poly(A) mRNAs. Binds to poly(G) and poly(A), but not to poly(U) or poly(C) RNA homopolymers. Binds to the 5'-ACUAGC-3' RNA consensus sequence.. | |
Protein Sequence | MEVPPRLSHVPPPLFPSAPATLASRSLSHWRPRPPRQLAPLLPSLAPSSARQGARRAQRHVTAQQPSRLAGGAAIKGGRRRRPDLFRRHFKSSSIQRSAAAAAATRTARQHPPADSSVTMEDMNEYSNIEEFAEGSKINASKNQQDDGKMFIGGLSWDTSKKDLTEYLSRFGEVVDCTIKTDPVTGRSRGFGFVLFKDAASVDKVLELKEHKLDGKLIDPKRAKALKGKEPPKKVFVGGLSPDTSEEQIKEYFGAFGEIENIELPMDTKTNERRGFCFITYTDEEPVKKLLESRYHQIGSGKCEIKVAQPKEVYRQQQQQQKGGRGAAAGGRGGTRGRGRGQGQNWNQGFNNYYDQGYGNYNSAYGGDQNYSGYGGYDYTGYNYGNYGYGQGYADYSGQQSTYGKASRGGGNHQNNYQPY | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
6 | Methylation | --MEVPPRLSHVPPP --CCCCCCHHCCCCC | 42.63 | 115479035 | |
7 (in isoform 2) | Phosphorylation | - | 5.25 | 25849741 | |
7 (in isoform 3) | Phosphorylation | - | 5.25 | 25849741 | |
8 | Phosphorylation | MEVPPRLSHVPPPLF CCCCCCHHCCCCCCC | 24.58 | 20068231 | |
8 (in isoform 2) | Phosphorylation | - | 24.58 | 25849741 | |
8 (in isoform 3) | Phosphorylation | - | 24.58 | 25849741 | |
17 | Phosphorylation | VPPPLFPSAPATLAS CCCCCCCCCCCHHHH | 39.28 | 20068231 | |
21 | Phosphorylation | LFPSAPATLASRSLS CCCCCCCHHHHCCCC | 23.07 | 20068231 | |
23 (in isoform 2) | Ubiquitination | - | 9.88 | 21890473 | |
23 (in isoform 3) | Ubiquitination | - | 9.88 | 21890473 | |
24 | Phosphorylation | SAPATLASRSLSHWR CCCCHHHHCCCCCCC | 26.05 | 20068231 | |
25 | Dimethylation | APATLASRSLSHWRP CCCHHHHCCCCCCCC | 35.69 | - | |
25 | Methylation | APATLASRSLSHWRP CCCHHHHCCCCCCCC | 35.69 | 24129315 | |
26 | Phosphorylation | PATLASRSLSHWRPR CCHHHHCCCCCCCCC | 31.56 | 28555341 | |
30 (in isoform 2) | Ubiquitination | - | 14.48 | 21890473 | |
30 (in isoform 3) | Ubiquitination | - | 14.48 | 21890473 | |
42 (in isoform 2) | Ubiquitination | - | 2.36 | 21890473 | |
42 (in isoform 3) | Ubiquitination | - | 2.36 | 21890473 | |
43 (in isoform 2) | Ubiquitination | - | 34.67 | 21890473 | |
43 (in isoform 3) | Ubiquitination | - | 34.67 | 21890473 | |
48 | Phosphorylation | LLPSLAPSSARQGAR CHHHCCCHHHHHHHH | 30.90 | 22210691 | |
49 | Phosphorylation | LPSLAPSSARQGARR HHHCCCHHHHHHHHH | 26.81 | 22210691 | |
61 (in isoform 2) | Ubiquitination | - | 5.30 | 21890473 | |
61 (in isoform 3) | Ubiquitination | - | 5.30 | 21890473 | |
67 | Phosphorylation | HVTAQQPSRLAGGAA HCCCCCCCHHHCCCC | 35.27 | 28555341 | |
68 | Methylation | VTAQQPSRLAGGAAI CCCCCCCHHHCCCCC | 34.93 | 115479031 | |
76 | Acetylation | LAGGAAIKGGRRRRP HHCCCCCCCCCCCCH | 51.06 | 25953088 | |
76 | Methylation | LAGGAAIKGGRRRRP HHCCCCCCCCCCCCH | 51.06 | 116251837 | |
76 | Ubiquitination | LAGGAAIKGGRRRRP HHCCCCCCCCCCCCH | 51.06 | - | |
78 (in isoform 2) | Ubiquitination | - | 18.21 | 21890473 | |
78 (in isoform 3) | Ubiquitination | - | 18.21 | 21890473 | |
81 | Methylation | AIKGGRRRRPDLFRR CCCCCCCCCHHHHHH | 53.79 | 115479039 | |
82 | Methylation | IKGGRRRRPDLFRRH CCCCCCCCHHHHHHH | 27.54 | 54556605 | |
85 (in isoform 2) | Ubiquitination | - | 3.89 | 21890473 | |
85 (in isoform 3) | Ubiquitination | - | 3.89 | 21890473 | |
94 | Phosphorylation | RRHFKSSSIQRSAAA HHHHHCHHHHHHHHH | 29.81 | 21406692 | |
98 | Phosphorylation | KSSSIQRSAAAAAAT HCHHHHHHHHHHHHH | 13.09 | 21406692 | |
105 | Phosphorylation | SAAAAAATRTARQHP HHHHHHHHHHHHHCC | 24.67 | 21406692 | |
115 (in isoform 2) | Ubiquitination | - | 47.41 | 21890473 | |
115 (in isoform 3) | Ubiquitination | - | 47.41 | 21890473 | |
116 | Phosphorylation | RQHPPADSSVTMEDM HHCCCCCCCCCHHHH | 28.90 | 27642862 | |
117 | Phosphorylation | QHPPADSSVTMEDMN HCCCCCCCCCHHHHH | 23.35 | 30576142 | |
119 | Phosphorylation | PPADSSVTMEDMNEY CCCCCCCCHHHHHHC | 19.45 | 28348404 | |
126 | Phosphorylation | TMEDMNEYSNIEEFA CHHHHHHCCCHHHHH | 11.30 | 28355574 | |
127 | Phosphorylation | MEDMNEYSNIEEFAE HHHHHHCCCHHHHHH | 25.75 | 21955146 | |
136 | Phosphorylation | IEEFAEGSKINASKN HHHHHHCCCCCCCCC | 23.13 | 26552605 | |
137 | Acetylation | EEFAEGSKINASKNQ HHHHHCCCCCCCCCC | 51.33 | 25953088 | |
137 | Ubiquitination | EEFAEGSKINASKNQ HHHHHCCCCCCCCCC | 51.33 | 21139048 | |
142 | 2-Hydroxyisobutyrylation | GSKINASKNQQDDGK CCCCCCCCCCCCCCC | 57.26 | - | |
142 | Ubiquitination | GSKINASKNQQDDGK CCCCCCCCCCCCCCC | 57.26 | 21906983 | |
142 (in isoform 1) | Ubiquitination | - | 57.26 | 21890473 | |
149 | Acetylation | KNQQDDGKMFIGGLS CCCCCCCCEEECEEC | 37.32 | 26051181 | |
149 | Ubiquitination | KNQQDDGKMFIGGLS CCCCCCCCEEECEEC | 37.32 | 21890473 | |
149 (in isoform 1) | Ubiquitination | - | 37.32 | 21890473 | |
150 | Sulfoxidation | NQQDDGKMFIGGLSW CCCCCCCEEECEECC | 3.46 | 28183972 | |
150 (in isoform 2) | Ubiquitination | - | 3.46 | 21890473 | |
150 (in isoform 3) | Ubiquitination | - | 3.46 | 21890473 | |
156 | Phosphorylation | KMFIGGLSWDTSKKD CEEECEECCCCCHHH | 26.61 | 24275569 | |
159 | Phosphorylation | IGGLSWDTSKKDLTE ECEECCCCCHHHHHH | 35.87 | 28857561 | |
160 | Phosphorylation | GGLSWDTSKKDLTEY CEECCCCCHHHHHHH | 34.92 | 28348404 | |
161 | 2-Hydroxyisobutyrylation | GLSWDTSKKDLTEYL EECCCCCHHHHHHHH | 53.01 | - | |
161 | Acetylation | GLSWDTSKKDLTEYL EECCCCCHHHHHHHH | 53.01 | 21339330 | |
161 | Methylation | GLSWDTSKKDLTEYL EECCCCCHHHHHHHH | 53.01 | 23644510 | |
161 | Ubiquitination | GLSWDTSKKDLTEYL EECCCCCHHHHHHHH | 53.01 | 21906983 | |
161 (in isoform 1) | Ubiquitination | - | 53.01 | 21890473 | |
162 | 2-Hydroxyisobutyrylation | LSWDTSKKDLTEYLS ECCCCCHHHHHHHHH | 58.71 | - | |
162 | Ubiquitination | LSWDTSKKDLTEYLS ECCCCCHHHHHHHHH | 58.71 | 21890473 | |
162 (in isoform 1) | Ubiquitination | - | 58.71 | 21890473 | |
165 | Phosphorylation | DTSKKDLTEYLSRFG CCCHHHHHHHHHHHC | 32.49 | 28796482 | |
167 | Phosphorylation | SKKDLTEYLSRFGEV CHHHHHHHHHHHCCE | 12.54 | 28796482 | |
169 | Phosphorylation | KDLTEYLSRFGEVVD HHHHHHHHHHCCEEE | 25.35 | 28796482 | |
177 | S-nitrosocysteine | RFGEVVDCTIKTDPV HHCCEEEEEEECCCC | 2.61 | - | |
177 | Glutathionylation | RFGEVVDCTIKTDPV HHCCEEEEEEECCCC | 2.61 | 22555962 | |
177 | S-nitrosylation | RFGEVVDCTIKTDPV HHCCEEEEEEECCCC | 2.61 | 22178444 | |
178 | Phosphorylation | FGEVVDCTIKTDPVT HCCEEEEEEECCCCC | 22.50 | 30576142 | |
180 | 2-Hydroxyisobutyrylation | EVVDCTIKTDPVTGR CEEEEEEECCCCCCC | 28.81 | - | |
180 | Acetylation | EVVDCTIKTDPVTGR CEEEEEEECCCCCCC | 28.81 | 25953088 | |
180 | Malonylation | EVVDCTIKTDPVTGR CEEEEEEECCCCCCC | 28.81 | 26320211 | |
180 | Ubiquitination | EVVDCTIKTDPVTGR CEEEEEEECCCCCCC | 28.81 | 21906983 | |
180 (in isoform 1) | Ubiquitination | - | 28.81 | 21890473 | |
181 | Phosphorylation | VVDCTIKTDPVTGRS EEEEEEECCCCCCCC | 41.50 | 23882029 | |
183 (in isoform 2) | Ubiquitination | - | 30.70 | - | |
185 | Phosphorylation | TIKTDPVTGRSRGFG EEECCCCCCCCCCEE | 32.06 | 23312004 | |
189 | Methylation | DPVTGRSRGFGFVLF CCCCCCCCCEEEEEE | 43.00 | - | |
192 (in isoform 2) | Ubiquitination | - | 17.99 | - | |
197 | Acetylation | GFGFVLFKDAASVDK CEEEEEEECCCCCHH | 42.15 | 25825284 | |
197 | Ubiquitination | GFGFVLFKDAASVDK CEEEEEEECCCCCHH | 42.15 | 21890473 | |
197 (in isoform 1) | Ubiquitination | - | 42.15 | 21890473 | |
204 | 2-Hydroxyisobutyrylation | KDAASVDKVLELKEH ECCCCCHHHHHHHHH | 46.71 | - | |
204 | Acetylation | KDAASVDKVLELKEH ECCCCCHHHHHHHHH | 46.71 | 25953088 | |
204 | Ubiquitination | KDAASVDKVLELKEH ECCCCCHHHHHHHHH | 46.71 | 21890473 | |
204 (in isoform 1) | Ubiquitination | - | 46.71 | 21890473 | |
209 | 2-Hydroxyisobutyrylation | VDKVLELKEHKLDGK CHHHHHHHHHCCCCC | 48.69 | - | |
209 | Acetylation | VDKVLELKEHKLDGK CHHHHHHHHHCCCCC | 48.69 | 26051181 | |
209 | Sumoylation | VDKVLELKEHKLDGK CHHHHHHHHHCCCCC | 48.69 | 28112733 | |
209 | Ubiquitination | VDKVLELKEHKLDGK CHHHHHHHHHCCCCC | 48.69 | - | |
216 | 2-Hydroxyisobutyrylation | KEHKLDGKLIDPKRA HHHCCCCCCCCHHHH | 41.77 | - | |
216 | Acetylation | KEHKLDGKLIDPKRA HHHCCCCCCCCHHHH | 41.77 | 19608861 | |
216 | Ubiquitination | KEHKLDGKLIDPKRA HHHCCCCCCCCHHHH | 41.77 | - | |
234 | Ubiquitination | KGKEPPKKVFVGGLS CCCCCCCCEEECCCC | 46.83 | 21890473 | |
234 (in isoform 1) | Ubiquitination | - | 46.83 | 21890473 | |
241 | Phosphorylation | KVFVGGLSPDTSEEQ CEEECCCCCCCCHHH | 24.81 | 19664994 | |
244 | Phosphorylation | VGGLSPDTSEEQIKE ECCCCCCCCHHHHHH | 41.23 | 30266825 | |
245 | Phosphorylation | GGLSPDTSEEQIKEY CCCCCCCCHHHHHHH | 46.66 | 30278072 | |
269 | Ubiquitination | IELPMDTKTNERRGF EECCCCCCCCCCCCE | 45.12 | 2190698 | |
269 (in isoform 1) | Ubiquitination | - | 45.12 | 21890473 | |
277 | Glutathionylation | TNERRGFCFITYTDE CCCCCCEEEEEECCC | 2.41 | 22555962 | |
280 | Phosphorylation | RRGFCFITYTDEEPV CCCEEEEEECCCHHH | 10.50 | 28152594 | |
281 | Phosphorylation | RGFCFITYTDEEPVK CCEEEEEECCCHHHH | 13.84 | 28152594 | |
282 | Phosphorylation | GFCFITYTDEEPVKK CEEEEEECCCHHHHH | 28.43 | 28152594 | |
288 | 2-Hydroxyisobutyrylation | YTDEEPVKKLLESRY ECCCHHHHHHHHHHH | 48.71 | - | |
288 | Acetylation | YTDEEPVKKLLESRY ECCCHHHHHHHHHHH | 48.71 | 26051181 | |
288 | Ubiquitination | YTDEEPVKKLLESRY ECCCHHHHHHHHHHH | 48.71 | - | |
295 | Nitration | KKLLESRYHQIGSGK HHHHHHHHCCCCCCC | 13.83 | - | |
295 | Phosphorylation | KKLLESRYHQIGSGK HHHHHHHHCCCCCCC | 13.83 | 22817900 | |
300 | Phosphorylation | SRYHQIGSGKCEIKV HHHCCCCCCCCEEEE | 36.39 | 28258704 | |
302 | 2-Hydroxyisobutyrylation | YHQIGSGKCEIKVAQ HCCCCCCCCEEEECC | 30.32 | - | |
302 | Acetylation | YHQIGSGKCEIKVAQ HCCCCCCCCEEEECC | 30.32 | 23749302 | |
302 | Ubiquitination | YHQIGSGKCEIKVAQ HCCCCCCCCEEEECC | 30.32 | - | |
303 | Glutathionylation | HQIGSGKCEIKVAQP CCCCCCCCEEEECCH | 8.14 | 22555962 | |
306 | Acetylation | GSGKCEIKVAQPKEV CCCCCEEEECCHHHH | 14.82 | 25953088 | |
306 | Ubiquitination | GSGKCEIKVAQPKEV CCCCCEEEECCHHHH | 14.82 | - | |
311 | 2-Hydroxyisobutyrylation | EIKVAQPKEVYRQQQ EEEECCHHHHHHHHH | 47.97 | - | |
311 | Acetylation | EIKVAQPKEVYRQQQ EEEECCHHHHHHHHH | 47.97 | 26051181 | |
311 | Succinylation | EIKVAQPKEVYRQQQ EEEECCHHHHHHHHH | 47.97 | 23954790 | |
311 | Ubiquitination | EIKVAQPKEVYRQQQ EEEECCHHHHHHHHH | 47.97 | - | |
314 | Phosphorylation | VAQPKEVYRQQQQQQ ECCHHHHHHHHHHHH | 12.09 | 19702290 | |
335 | Phosphorylation | AAGGRGGTRGRGRGQ CCCCCCCCCCCCCCC | 32.54 | 22985185 | |
387 | Phosphorylation | TGYNYGNYGYGQGYA CCEECCCCCCCCCCC | 13.83 | - | |
389 | Phosphorylation | YNYGNYGYGQGYADY EECCCCCCCCCCCCC | 8.91 | - | |
396 | Phosphorylation | YGQGYADYSGQQSTY CCCCCCCCCCCCCCC | 13.41 | - | |
408 | Dimethylation | STYGKASRGGGNHQN CCCCCCCCCCCCCCC | 53.27 | - | |
408 | Methylation | STYGKASRGGGNHQN CCCCCCCCCCCCCCC | 53.27 | 15782174 | |
417 | Phosphorylation | GGNHQNNYQPY---- CCCCCCCCCCC---- | 20.58 | - | |
420 | Phosphorylation | HQNNYQPY------- CCCCCCCC------- | 18.70 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of HNRDL_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of HNRDL_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
609115 | Limb-girdle muscular dystrophy 1G (LGMD1G) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-216, AND MASS SPECTROMETRY. | |
Methylation | |
Reference | PubMed |
"Identifying and quantifying in vivo methylation sites by heavy methylSILAC."; Ong S.E., Mittler G., Mann M.; Nat. Methods 1:119-126(2004). Cited for: METHYLATION [LARGE SCALE ANALYSIS] AT ARG-408, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-241, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-241, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-241, AND MASSSPECTROMETRY. |